Molecular Diagnostics Market (PCR, Next Generation Sequencing, Microarray, Infectious diseases, Genetic disease, Oncology testing, Blood donor screening) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 - Tucson News Now

Molecular Diagnostics Market (PCR, Next Generation Sequencing, Microarray, Infectious diseases, Genetic disease, Oncology testing, Blood donor screening) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Reportlinker

NEW YORK, Feb. 25, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Molecular Diagnostics Market (PCR, Next Generation Sequencing, Microarray, Infectious diseases, Genetic disease, Oncology testing, Blood donor screening) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
http://www.reportlinker.com/p02038610/Molecular-Diagnostics-Market-PCR-Next-Generation-Sequencing-Microarray-Infectious-diseases-Genetic-disease-Oncology-testing-Blood-donor-screening---Global-Industry-Analysis-Size-Share-Growth-Trends-and-Forecast-2013---2019.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Molecular diagnostics is defined as a class of diagnostic tests which identifies genetic and molecular biomarkers of an individual patient. It is essentially an analysis of RNA and DNA at the molecular level. This class of diagnostics tests is considered as the most well established and lucrative market in the clinical applications segment. Traditionally, usage of molecular diagnostics was limited due to requirement of highly skilled professionals and high cost of tests. However, recent reduction in cost per sample analysis, labor costs, improvements in automation and introduction of advanced technologies have expanded the usage of molecular diagnostics tests. The growth of this market is expected to surge due to various factors such as rise in incidence of hospital acquired infections, increase in patient awareness along with growing elderly population. Additionally, outbreak of diseases such as H1N1, growing incidence of diseases such as HIV and hepatitis have augmented the growth of this market.

The research report on molecular diagnostics provides detailed analysis of the global market and helps in understanding the driving forces responsible for its growth. The report discusses the molecular diagnostics market on the basis of different technologies and applications. The technology segment comprises polymerase chain reaction (PCR), transcription mediated amplification (TMA), hybridization technique, microarray, sequencing and others. The application segment is classified into infectious diseases, blood donor screening and genomics. The genomics segmented is further classified into genetic disorders, oncology, HLA testing and pharmacogenetics testing. The infectious diseases segment comprises market for HIV infections, HAI, HCV infections and others. Market size estimates and forecasts for the period 2011 to 2019 have been provided for each of the segments in terms of USD million using 2012 as the base year. The CAGR (%) of each market segment for the forecast period 2013 to 2019 has been provided along with market size estimations.

The market has also been segmented geographically into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW), and respective market sizes and forecasts have been provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global molecular diagnostics market, and future opportunities has been provided in the market overview section. This section also features a detailed market attractiveness analysis and Porter's five forces analysis for the molecular diagnostics market.

Market players are profiled on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Some of the major players profiled in this report include Abbott Laboratories, Becton Dickinson & Company, Cepheid, Roche Diagnostics and others.

The global molecular diagnosticsmarket is segmented into the following categories:

Molecular DiagnosticsMarket, by Technology

PCR
Transcription mediated amplification (TMA)
Next generation sequencing
Microarray
Hybridization techniques
Others

Molecular DiagnosticsMarket, by Application
Infectious diseases
Virology
HIV testing
HPV testing
HCV testing
Others
Bacteriology
HAI testing

CT/NG testing
Others
Genomics
Genetic testing for inherited disorders
Human Leukocyte Antigen (HLA) testing
Pharmacogenetics testing
Oncology Testing
Blood Donor Screening
Others

Molecular DiagnosticsMarket, by Geography
North America
Europe
Asia-Pacific
RoW

Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Molecular Diagnostics Market (2012 & 2019)
2.2 Global Molecular Diagnostics Market, by Technology, 2012 (USD Million)

Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Rising incidence of cancer cases
3.2.2 Aging population
3.2.3 Increase in incidence of chronic diseases
3.2.4 Increasing awareness and acceptance of companion diagnostics and personalized medicines
3.3 Market Restraints
3.3.1 Issues with reimbursement policies

3.4 Market Opportunities
3.4.1 Technological advancements
3.4.2 Tapping the emerging economies
3.5 Porter's Five Force Analysis: Global Molecular Diagnostics Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of New Entrants
3.5.4 Threat of Substitutes
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis of the Global Molecular Diagnostics Market, by Geography

Chapter 4 Molecular Diagnostics Market, by Technology
4.1 Overview
4.1.1 Global Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
4.2 Polymerase Chain Reaction (PCR)
4.2.1 Global PCR Market, 2011 – 2019 (USD Million)

4.3 Transcription Mediated Amplification (TMA)
4.3.1 Global TMA Market, 2011 – 2019 (USD Million)
4.4 Microarray
4.4.1 Global Microarray Market, 2011 – 2019 (USD Million)
4.5 Hybridization (ISH and FISH)
4.5.1 Global Hybridization Market, 2011 – 2019 (USD Million)
4.6 Next-generation sequencing
4.6.1 Global Next generation sequencing Market, 2011 – 2019 (USD Million)
4.7 Others
4.7.1 Global Others Market, 2011 – 2019 (USD Million)

Chapter 5 Global Molecular Diagnostics Market, by Applications
5.1 Overview
5.1.1 Global Molecular Diagnostics Market, by Applications, 2011 – 2019 (USD Million)
5.2 Infectious Diseases
5.2.1 Global Infectious Diseases Market, by Segments, 2011 – 2019 (USD Million)
5.2.2 Virology
5.2.2.1 Global Virology Market, by Segments, 2011 – 2019 (USD Million)
5.2.2.2 Human immunodeficiency virus (HIV) testing
5.2.2.2.1 Global HIV testing Market, 2011 – 2019 (USD Million)
5.2.2.3 Human papillomavirus (HPV) testing
5.2.2.3.1 Global HPV testing Market, 2011 – 2019 (USD Million)
5.2.2.4 Hepatitis C virus (HCV) testing
5.2.2.4.1 Global HCV testing Market, 2011 – 2019 (USD Million)
5.2.2.5 Others
5.2.2.5.1 Global Others testing Market, 2011 – 2019 (USD Million)
5.2.3 Bacteriology
5.2.3.1 Global Bacteriology Market, by Segments, 2011 – 2019 (USD Million)
5.2.3.2 Hospital Acquired Infection (HAI) testing
5.2.3.2.1 Global HAI testing Market, 2011 – 2019 (USD Million)

5.2.3.3 Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) testing
5.2.3.3.1 Global CT/NG testing Market, 2011 – 2019 (USD Million)
5.2.3.4 Others
5.2.3.4.1 Global Others testing Market, 2011 – 2019 (USD Million)
5.3 Genomics
5.3.1 Global Genomics Market, by Segments, 2011 – 2019 (USD Million)
5.3.2 Genetic testing for inherited disorders
5.3.2.1 Global Genetic testing for inherited disorders Market, 2011 – 2019 (USD Million)
5.3.3 Human Leukocyte Antigen (HLA)testing
5.3.3.1 Global HLA testing Market, 2011 – 2019 (USD Million)
5.3.4 Pharmacogenetics testing
5.3.4.1 Global Pharmacogenetics testing Market, 2011 – 2019 (USD Million)
5.3.5 Oncology testing
5.3.5.1 Global Oncology testing Market, 2011 – 2019 (USD Million)
5.4 Blood Donor Screening
5.4.1 Global Blood donor screening testing Market, 2011 – 2019 (USD Million)
5.5 Others
5.5.1 Global Others testing Market, 2011 – 2019 (USD Million)

Chapter 6 Global Molecular Diagnostics Market, by Geography
6.1 Overview
6.1.1 Global Molecular Diagnostics Market, by Geography, 2011 – 2019 (USD Million)
6.2 Comparative Analysis: Molecular Diagnostics Market, by Geography, 2012 & 2019 (Value %)
6.3 North America
6.3.1 North America Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million)
6.3.2 North America Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
6.4 Europe
6.4.1 Europe Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million)
6.4.2 Europe Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
6.5 Asia-Pacific
6.5.1 Asia Pacific Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million)
6.5.2 Asia-Pacific Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
6.6 RoW
6.6.1 RoW Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million)
6.6.2 RoW Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)

Chapter 7 Global Molecular Diagnostics Market Share Analysis
7.1 Market Share Analysis by Key Players of Global Molecular Diagnostics Market
7.1.1 Global Molecular Diagnostics Market Share Analysis, by Key Players, 2012 (%)
7.1.2 Competitive Position of Key Players by Segment : Global Molecular Diagnostics Market

Chapter 8 Recommendations
8.1 Market Strategies for Success
8.1.1 Long term contracts with healthcare service providers
8.1.2 Investing in emerging economies such as China, India and Russia
8.1.3 Broadening of distribution network

Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Overview

9.1.3 Product Portfolio
9.1.4 Business Strategies
9.1.5 Recent Developments
9.2 Becton Dickinson & Company
9.2.1 Company Overview
9.2.2 Financial Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.2.5 Recent Developments
9.3 bioMerieux
9.3.1 Company Overview
9.3.2 Financial Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.3.5 Recent Developments
9.4 Bio-Rad
9.4.1 Company Overview
9.4.2 Financial Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies
9.4.5 Recent Developments

9.5 Cepheid
9.5.1 Company Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.5.5 Recent Developments
9.6 Danaher Corporation (Beckman Coulter)
9.6.1 Company Overview
9.6.2 Financial Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies
9.6.5 Recent Developments
9.7 F. Hoffmann-La Roche Ltd.

9.7.1 Company Overview
9.7.2 Financial Overview
9.7.3 Product Portfolio
9.7.4 Business Strategies
9.7.5 Recent Developments
9.8 Hologic, Inc. (Gen-Probe)
9.8.1 Company Overview
9.8.2 Financial Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies
9.8.5 Recent Developments
9.9 Myriad Genetics, Inc.
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Product Portfolio
9.9.4 Business Strategies
9.9.5 Recent Developments
9.10 Novartis International AG
9.10.1 Company Overview
9.10.2 Financial Overview

9.10.3 Product Portfolio
9.10.4 Business Strategies
9.11 Qiagen
9.11.1 Company Overview
9.11.2 Financial Overview
9.11.3 Product Portfolio
9.11.4 Business Strategies
9.11.5 Recent Developments
9.12 Quest Diagnostics, Inc.
9.12.1 Company Overview
9.12.2 Financial Overview
9.12.3 Product Portfolio
9.12.4 Business Strategies
9.12.5 Recent Developments
9.13 Siemens AG
9.13.1 Company Overview
9.13.2 Financial Overview
9.13.3 Product Portfolio
9.13.4 Business Strategies
9.13.5 Recent Developments
9.14 Thermo Fisher Scientific

9.14.1 Company Overview
9.14.2 Financial Overview
9.14.3 Product Portfolio
9.14.4 Business Strategies
9.14.5 Recent Developments

List of Figures

FIG. 1 Molecular Diagnostics: Market Segmentation
FIG. 2 Global Molecular Diagnostics Market, by Technology, 2012 (USD Million)
FIG. 1 Porter's Five Force Analysis: Global Molecular Diagnostics Market
FIG. 2 Market Attractiveness Analysis : Global Molecular Diagnostics Market, by Geography
FIG. 3 Global PCR Market, 2011 – 2019 (USD Million)
FIG. 4 Global TMA Market, 2011 – 2019 (USD Million)
FIG. 5 Global Microarray Market, 2011 – 2019 (USD Million)
FIG. 6 Global Hybridization Market, 2011 – 2019 (USD Million)
FIG. 7 Global Next generation sequencing Market, 2011 – 2019 (USD Million)

FIG. 8 Global Others Market, 2011 – 2019 (USD Million)
FIG. 9 Global HIV testing Market, 2011 – 2019 (USD Million)
FIG. 10 Global HPV testing Market, 2011 – 2019 (USD Million)
FIG. 11 Global HCV testing Market, 2011 – 2019 (USD Million)
FIG. 12 Global Others testing Market, 2011 – 2019 (USD Million)
FIG. 13 Global HAI testing Market, 2011 – 2019 (USD Million)
FIG. 14 Global CT/NG testing Market, 2011 – 2019 (USD Million)

IG. 15 Global Others testing Market, 2011 – 2019 (USD Million)
FIG. 16 Global Genetic testing for inherited disorders Market, 2011 – 2019 (USD Million)
FIG. 17 Global HLA testing Market, 2011 – 2019 (USD Million)
FIG. 18 Global Pharmacogenetics testing Market, 2011 – 2019 (USD Million)
FIG. 19 Global Oncology testing Market, 2011 – 2019 (USD Million)
FIG. 20 Global Blood donor screening testing Market, 2011 – 2019 (USD Million)
FIG. 21 Global Others testing Market, 2011 – 2019 (USD Million)
FIG. 22 Comparative Analysis: Molecular Diagnostics Market, by Geography, 2012 & 2019 (Value %)
FIG. 23 Global Molecular Diagnostics: Market Share, by Key Players, 2012 (%)
FIG. 24 Abbott Laboratories, Inc., Annual Revenue, 2010 – 2012 (USD Million)
FIG. 25 Becton Dickinson: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 26 bioMerieux: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 27 Bio-Rad: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 28 Cepheid: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 29 Danaher Corporation: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 30 F. Hoffmann-La Roche Ltd.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 31 Hologic, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 32 Myriad Genetics, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 33 Novartis International AG.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 34 Qiagen N.V.,: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 35 Quest Diagnostics: Annual Revenue,2010 – 2012 (USD Million)
FIG. 36 Siemens AG : Annual Revenue, 2010 – 2012 (USD Million)
FIG. 37 Thermo Fisher Scientific: Annual Revenue,2010 – 2012 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Molecular Diagnostics Market (2012 & 2019)
TABLE 2 Global Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
TABLE 3 Global Molecular Diagnostics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 4 Global Infectious Diseases Market, by Segments, 2011 – 2019 (USD Million)
TABLE 5 Global Virology Market, by Segments, 2011 – 2019 (USD Million)
TABLE 6 Global Bacteriology Market, by Segments, 2011 – 2019 (USD Million)
TABLE 7 Global Genomics Market, by Segments, 2011 – 2019 (USD Million)
TABLE 8 Global Molecular Diagnostics Market, by Geography, 2011 – 2019 (USD Million)
TABLE 9 North America Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million)
TABLE 10 North America Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
TABLE 11 Europe Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million)
TABLE 12 Europe Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
TABLE 13 Asia Pacific Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million)
TABLE 14 Asia-Pacific Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
TABLE 15 RoW Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million)
TABLE 16 RoW Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
TABLE 17 Competitive Position of Key Players by Segment : Global Molecular Diagnostics Market (2012)

To order this report: Molecular Diagnostics Market (PCR, Next Generation Sequencing, Microarray, Infectious diseases, Genetic disease, Oncology testing, Blood donor screening) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
http://www.reportlinker.com/p02038610/Molecular-Diagnostics-Market-PCR-Next-Generation-Sequencing-Microarray-Infectious-diseases-Genetic-disease-Oncology-testing-Blood-donor-screening---Global-Industry-Analysis-Size-Share-Growth-Trends-and-Forecast-2013---2019.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow